The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia

Schizophrenia Bulletin

Volumn 39, Issue 6, 2013, Pages 1242-1251

  Barkhof, Emile ^a   Meijer, Carin J ^a   De Sonneville, Leo M J ^b   Linszen, Don H ^c   De Haan, Lieuwe ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Intervention study; Medication adherence; Motivational interviewing; RCT; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH EDUCATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MENTAL PATIENT; MOTIVATIONAL INTERVIEWING; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT REFUSAL; URINALYSIS;

INTERVENTION STUDY; MEDICATION ADHERENCE; MOTIVATIONAL INTERVIEWING; RCT; SCHIZOPHRENIA;

ADULT; AGE FACTORS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; PATIENT EDUCATION AS TOPIC; RECURRENCE; SCHIZOPHRENIA; SEX FACTORS; TREATMENT OUTCOME;

EID: 84886010965     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt138     Document Type: Article

References (37)

1. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892-909. (Pubitemid 35231730)
2. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21:419-429.
3. Robinson D, Woerner MG, Alvir JM, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56:241-247. (Pubitemid 29125132)
4. Heeg B, Buskens E, Knapp M, et al. Modelling the treated course of schizophrenia: development of a discrete event simulation model. Pharmacoeconomics. 2005;23(suppl 1):17-33.
5. Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia-a review of the past decade. Eur Psychiatry. 2012;27:9-18.
6. Velligan DI, Weiden PJ, Sajatovic M, et al. Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(suppl 4):1-46; quiz 47.
7. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. New York, NY: Guilford Press; 2002.
8. Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction. 1993;88:315-335. (Pubitemid 23095974)
9. Noonan WC, Moyers TB. Motivational interviewing: a review. J Subst Misuse. 1997;2:8-16.
10. Harland J, White M, Drinkwater C, Chinn D, Farr L, Howel D. The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care. BMJ. 1999;319:828-832. (Pubitemid 29445923)
11. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843-861. (Pubitemid 37151548)
12. Lundahl B, Burke BL. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol. 2009;65:1232-1245.
13. Barkhof E, de Haan L, Meijer CJ, et al. Motivational interviewing in psychotic disorders. Curr Psychiatr Rev. 2006;2:207-213. (Pubitemid 44027878)
14. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996;312:345-349. (Pubitemid 26050038)
15. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413-419. (Pubitemid 28204550)
16. O'Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. 2003;327:834.
17. Gray R, Leese M, Bindman J, et al. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry. 2006;189:508-514. (Pubitemid 44876869)
18. Maneesakorn S, Robson D, Gournay K, Gray R. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs. 2007;16:1302-1312.
19. Staring AB, Van der Gaag M, Koopmans GT, et al. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br J Psychiatry. 2010;197:448-455.
20. Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry. 2006;67(suppl 5):3-8. (Pubitemid 43837695)
21. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
22. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education and Welfare Publication (ADM), National Institute of Mental Health; 1976:76-338.
23. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory - European Version: development of an instrument for international research. Br J Psychiatry Suppl. 2000;177:s28-s33. (Pubitemid 30447744)
24. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. (Pubitemid 16125389)
25. Susser E, Finnerty M, Mojtabai R, et al. Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophr Res. 2000;42:67-77. (Pubitemid 30118745)
26. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13:177-183. (Pubitemid 13132147)
27. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276. (Pubitemid 18039085)
28. Kashner TM, Rader LE, Rodell DE, Beck CM, Rodell LR, Muller K. Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Psychiatr Serv. 1991;42:195-197.
29. Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91-111. (Pubitemid 43843947)
30. Smeerdijk M, Keet R, Dekker N, et al. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. Psychol Med. 2012;42:1627-1636.
31. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23:637-651. (Pubitemid 27485972)
32. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment. 2012;2012:916198.
33. Foti DJ, Kotov R, Guey LT, Bromet EJ. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry. 2010;167:987-993.
34. Kikkert MJ, Barbui C, Koeter MW, et al. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research. J Nerv Ment Dis. 2008;196:274-281. (Pubitemid 351548727)
35. Valenstein M, Kavanagh J, Lee T, et al. Using a pharmacybased intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull. 2011;37:727-736.
36. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316:1236-1238. (Pubitemid 28171344)
37. Storosum J, van Zwieten B, de Haan L. Informed consent from behaviourally disturbed patients. Lancet. 2002;359:83. (Pubitemid 34119217)